AstraZeneca

Should you buy this stock after it reports a 27% rise in revenue?

Is this company set to soar after positive results? More »

Forget short-term pain! Buy these FTSE 100 stars for long-term gain

Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors. More »

These FTSE 100 beauties are just too cheap to miss!

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) firecrackers trading far, far too cheaply. More »

These dividend stocks won’t yield 4%+ forever

Getting a 4%+ yield from these shares beats savings accounts, but may not be available for much longer. More »

These two FTSE 100 dividends stars still look cheap

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued. More »

Do these 3 low yielders offer high growth prospects?

A sky-high yield isn't everything these days, is it? Harvey Jones investigates. More »

Is this a better healthcare buy than AstraZeneca plc after today’s update?

Will this healthcare stock keep beating AstraZeneca plc (LON: AZN)? More »

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN) in the pharma stakes? More »

These two large caps look seriously undervalued

These two large caps could be the most undervalued in the FTSE 100. More »

Should you pile into this healthcare stock after today’s update?

Is this healthcare stock a 'must-buy'? More »

Can you really trust these Footsie big yielders to pay out?

Royston Wild discusses the payout prospects of three FTSE 100 dividend stocks. More »

Is this the best healthcare stock money can buy after today’s update?

Should you buy this stock or a sector peer following today's news? More »

These FTSE 100 giants sank in August! Can they bounce back?

Royston Wild looks at the share price prospects of three recent FTSE 100 (INDEXFTSE: UKX) fallers. More »

Is now the right time to buy these Neil Woodford dividend stocks?

In the light of recent gains, Roland Head takes a fresh look at three of fund manager Neil Woodford's biggest holdings. More »

Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?

Edward Sheldon looks at Hikma Pharmaceuticals plc's (LON: HIK) interim results statement and examines whether the long-term growth story is still intact. More »

What does AstraZeneca plc’s deal with Pfizer mean for shareholders?

Should you buy, sell or hold AstraZeneca plc (LON: AZN) after the company's Pfizer deal? More »

3 stocks to help you retire early

Retirement planning requires a long-term view and these three shares could bring retirement a big step closer. More »

Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?

After recent gains is it time to sell GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)? More »

These FTSE 100 stars have exploded in Q3! And they’re not finished yet

Royston Wild considers the share price potential of three FTSE 100 (INDEXFTSE: UKX) fireworks. More »

Why now is the perfect time to buy these 3 super income stocks

These three shares look set to deliver strong returns over the medium-to-long term and the interest rate cut could make them even more attractive. More »